Clinical Trial Update: Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating body surface area-based dosing versus concentration-based dosing of cisplatin for HIPEC in women with advanced ovarian cancer. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: FIGO Stage III Ovarian Cancer, Peritoneal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING